Cargando…

U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease

PURPOSE: In the anaerobic metabolic pathway, lactate dehydrogenase (LDH) plays an important role in hypoxia, inflammation, and cell damage, making it a potential biomarker for the progression of chronic obstructive pulmonary disease (COPD). We aimed to examine the relationship between LDH levels and...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lihua, Lu, Zhanpeng, Zhou, Xiaoqing, He, Liuliu, You, Xiaoyan, Chen, Chunmei, Zou, Chunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024872/
https://www.ncbi.nlm.nih.gov/pubmed/36945707
http://dx.doi.org/10.2147/COPD.S386269
_version_ 1784909203769393152
author Huang, Lihua
Lu, Zhanpeng
Zhou, Xiaoqing
He, Liuliu
You, Xiaoyan
Chen, Chunmei
Zou, Chunsheng
author_facet Huang, Lihua
Lu, Zhanpeng
Zhou, Xiaoqing
He, Liuliu
You, Xiaoyan
Chen, Chunmei
Zou, Chunsheng
author_sort Huang, Lihua
collection PubMed
description PURPOSE: In the anaerobic metabolic pathway, lactate dehydrogenase (LDH) plays an important role in hypoxia, inflammation, and cell damage, making it a potential biomarker for the progression of chronic obstructive pulmonary disease (COPD). We aimed to examine the relationship between LDH levels and all-cause mortality in participants with COPD. PATIENTS AND METHODS: Data of participants in the US National Health and Nutrition Examination Surveys (NHANES) 2007–2012 aged ≥20 years who underwent spirometry tests were examined, and follow-up mortality data were obtained. According to serum LDH levels, participants with COPD were divided into five groups (59–111, 112–123, 124–135, 136–150, and 151–344 U/L). To evaluate whether LDH levels were independently associated with COPD mortality, we used multivariate Cox regression analysis and smooth curve fitting. RESULTS: We included 1320 subjects, 64 with stage III or IV COPD and 541 with stage II COPD. Over a median follow-up of 9.7 years (IQR: 7.8, 11.2), 252 of the 1320 subjects died. The mean LDH level was 132.5 U/L (standard deviation [SD], 27.0). A U-shaped relationship was observed between LDH levels and all-cause mortality. Below and above the inflection point, which was approximately 110 U/L, we found different slopes for the correlation between LDH and all-cause mortality of patients with COPD. Below the threshold, per 1-standard deviation (1SD) increase in LDH resulted in a 68% reduced risk of all-cause mortality (hazard ratio [HR] 0.32, 95% confidence interval [CI] 0.13–0.81, P=0.016); conversely, above the threshold, per 1SD increase in LDH accelerated the risk of all-cause mortality (HR 1.23, 95% CI: 1.08–1.41, P= 0.002). CONCLUSION: Using the nationally representative NHANES data, we found a U-shaped association between LDH level and all-cause mortality in participants with COPD. An optimal LDH level of approximately 110 U/L was associated with the lowest risk of all-cause mortality.
format Online
Article
Text
id pubmed-10024872
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-100248722023-03-20 U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease Huang, Lihua Lu, Zhanpeng Zhou, Xiaoqing He, Liuliu You, Xiaoyan Chen, Chunmei Zou, Chunsheng Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: In the anaerobic metabolic pathway, lactate dehydrogenase (LDH) plays an important role in hypoxia, inflammation, and cell damage, making it a potential biomarker for the progression of chronic obstructive pulmonary disease (COPD). We aimed to examine the relationship between LDH levels and all-cause mortality in participants with COPD. PATIENTS AND METHODS: Data of participants in the US National Health and Nutrition Examination Surveys (NHANES) 2007–2012 aged ≥20 years who underwent spirometry tests were examined, and follow-up mortality data were obtained. According to serum LDH levels, participants with COPD were divided into five groups (59–111, 112–123, 124–135, 136–150, and 151–344 U/L). To evaluate whether LDH levels were independently associated with COPD mortality, we used multivariate Cox regression analysis and smooth curve fitting. RESULTS: We included 1320 subjects, 64 with stage III or IV COPD and 541 with stage II COPD. Over a median follow-up of 9.7 years (IQR: 7.8, 11.2), 252 of the 1320 subjects died. The mean LDH level was 132.5 U/L (standard deviation [SD], 27.0). A U-shaped relationship was observed between LDH levels and all-cause mortality. Below and above the inflection point, which was approximately 110 U/L, we found different slopes for the correlation between LDH and all-cause mortality of patients with COPD. Below the threshold, per 1-standard deviation (1SD) increase in LDH resulted in a 68% reduced risk of all-cause mortality (hazard ratio [HR] 0.32, 95% confidence interval [CI] 0.13–0.81, P=0.016); conversely, above the threshold, per 1SD increase in LDH accelerated the risk of all-cause mortality (HR 1.23, 95% CI: 1.08–1.41, P= 0.002). CONCLUSION: Using the nationally representative NHANES data, we found a U-shaped association between LDH level and all-cause mortality in participants with COPD. An optimal LDH level of approximately 110 U/L was associated with the lowest risk of all-cause mortality. Dove 2023-03-15 /pmc/articles/PMC10024872/ /pubmed/36945707 http://dx.doi.org/10.2147/COPD.S386269 Text en © 2023 Huang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Huang, Lihua
Lu, Zhanpeng
Zhou, Xiaoqing
He, Liuliu
You, Xiaoyan
Chen, Chunmei
Zou, Chunsheng
U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease
title U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease
title_full U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease
title_fullStr U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease
title_full_unstemmed U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease
title_short U-Shaped Relationship Between Serum Lactate Dehydrogenase with All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease
title_sort u-shaped relationship between serum lactate dehydrogenase with all-cause mortality in patients with chronic obstructive pulmonary disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024872/
https://www.ncbi.nlm.nih.gov/pubmed/36945707
http://dx.doi.org/10.2147/COPD.S386269
work_keys_str_mv AT huanglihua ushapedrelationshipbetweenserumlactatedehydrogenasewithallcausemortalityinpatientswithchronicobstructivepulmonarydisease
AT luzhanpeng ushapedrelationshipbetweenserumlactatedehydrogenasewithallcausemortalityinpatientswithchronicobstructivepulmonarydisease
AT zhouxiaoqing ushapedrelationshipbetweenserumlactatedehydrogenasewithallcausemortalityinpatientswithchronicobstructivepulmonarydisease
AT heliuliu ushapedrelationshipbetweenserumlactatedehydrogenasewithallcausemortalityinpatientswithchronicobstructivepulmonarydisease
AT youxiaoyan ushapedrelationshipbetweenserumlactatedehydrogenasewithallcausemortalityinpatientswithchronicobstructivepulmonarydisease
AT chenchunmei ushapedrelationshipbetweenserumlactatedehydrogenasewithallcausemortalityinpatientswithchronicobstructivepulmonarydisease
AT zouchunsheng ushapedrelationshipbetweenserumlactatedehydrogenasewithallcausemortalityinpatientswithchronicobstructivepulmonarydisease